FKBP9

Across TCGA pan-cancer cohorts, FKBP9 mass-spec protein is linked to patient survival in 8 of 34 cancer types, making it a survival-associated FKBP9 data layer compared with 26 for mass-spec protein and 5 for mutation status.

The strongest signal is observed in pancreatic ductal adenocarcinoma (PDAC), where higher FKBP9 mass-spec protein is associated with worse overall survival. In most high-consensus cancer types, elevated FKBP9 expression acts as an unfavorable survival marker.

PDAC, CCRCC, and HNSC are the cancer types where FKBP9 mass-spec protein most reproducibly stratifies survival.

mass-spec protein survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
PDAC	OS	Quartile	All	0.264	0.520	.004	41	view →
CCRCC	OS	Median	All	0.605	1.000	.001	39	view →
HNSC	OS	Median	IV	0.589	0.914	<.001	28	view →
LUAD	DFS	Quartile	All	0.434	0.762	.005	15	view →
COAD	DFS	Median	IV	0.493	0.944	.031	6	view →
GBM	OS	Quartile	All	0.748	0.886	.024	4	view →
UCEC	OS	Tertile	All	0.899	1.000	.025	2	view →
LSCC	OS	Quartile	II,III,IV	0.733	0.933	.044	1	view →

Pink = unfavorable, green = favorable. Showing the 8 strongest of 8 lineages.

FKBP9–PDAC (OS)

Open the PDAC breakdown →